Literature DB >> 17610313

Etanercept-related extensive pulmonary nodulosis in a patient with rheumatoid arthritis.

Annelies van Ede1, Alfons den Broeder, Michiel Wagenaar, Piet van Riel, Marjonne C W Creemers.   

Abstract

OBJECTIVE: Although nodulosis is a common extraarticular manifestation of rheumatoid arthritis, accelerated pulmonary nodulosis is a rare event. The etiology of rheumatoid nodules is still unknown. Nodulosis is not necessarily associated with active joint inflammation, suggesting different pathogenic mechanisms for nodule formation and synovial tissue inflammation. We describe a patient with extensive pulmonary nodulosis, probably related to etanercept treatment. Our case emphasizes the need for careful monitoring for adverse events during treatment with biologicals, especially since the differential diagnosis often includes a broad spectrum of diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17610313

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  10 in total

Review 1.  Cutaneous nodules in patients with rheumatoid arthritis: a case report and review of literatures.

Authors:  Tadashi Nakamura; Syu-ichi Higashi; Kunihiko Tomoda; Michishi Tsukano; Ken-ichi Iyama
Journal:  Clin Rheumatol       Date:  2010-11-04       Impact factor: 2.980

Review 2.  Skin Manifestations of Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, and Spondyloarthritides.

Authors:  Carolyn Jean Chua-Aguilera; Burkhard Möller; Nikhil Yawalkar
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 8.667

3.  [Regression of peripheral and pulmonary rheumatoid nodules under therapy with rituximab].

Authors:  M G Braun; P Wagener
Journal:  Z Rheumatol       Date:  2013-03       Impact factor: 1.372

Review 4.  The utility of bronchoscopy in immunocompromised patients: a review.

Authors:  Christopher Morton; Jonathan Puchalski
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

Review 5.  Pulmonary complications of tumor necrosis factor-targeted therapy.

Authors:  Krishna Thavarajah; Peggy Wu; Elisa J Rhew; Anjana K Yeldandi; David W Kamp
Journal:  Respir Med       Date:  2009-02-07       Impact factor: 3.415

Review 6.  Intra-thoracic rheumatoid arthritis: Imaging spectrum of typical findings and treatment related complications.

Authors:  Thanissara Chansakul; Paul F Dellaripa; Tracy J Doyle; Rachna Madan
Journal:  Eur J Radiol       Date:  2015-07-17       Impact factor: 3.528

Review 7.  Recurrent pneumothorax associated with pulmonary nodules after leflunomide therapy in rheumatoid arthritis: a case report and review of the literature.

Authors:  Sun-Hee Kim; Wan-Hee Yoo
Journal:  Rheumatol Int       Date:  2009-10-28       Impact factor: 2.631

8.  Formation of multiple pulmonary nodules during treatment with leflunomide.

Authors:  Gilberto Toshikawa Yoshikawa; George Alberto da Silva Dias; Satomi Fujihara; Luigi Ferreira e Silva; Lorena de Britto Pereira Cruz; Hellen Thais Fuzii; Roberta Vilela Lopes Koyama
Journal:  J Bras Pneumol       Date:  2015 May-Jun       Impact factor: 2.624

Review 9.  Lung Infections in Systemic Rheumatic Disease: Focus on Opportunistic Infections.

Authors:  Manuela Di Franco; Bruno Lucchino; Martina Spaziante; Cristina Iannuccelli; Guido Valesini; Giancarlo Iaiani
Journal:  Int J Mol Sci       Date:  2017-01-29       Impact factor: 5.923

10.  Biological therapies for the treatment of juvenile idiopathic arthritis: Lessons from the adult and pediatric experiences.

Authors:  Matthew L Stoll; Alisa C Gotte
Journal:  Biologics       Date:  2008-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.